PEPGEN INC. (PEPG) ROA
- 2026-06-30: ROA -50.88%.
- 2026-03-31: ROA -49.40%.
- 2025-12-31: ROA -51.55%.
- 2025-09-30: ROA -49.23%.
Complete source-backed roa history.
- Available history
- 2021-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -50.88% |
| 2026-03-31 | -49.40% |
| 2025-12-31 | -51.55% |
| 2025-09-30 | -49.23% |
| 2025-06-30 | -94.79% |
| 2025-03-31 | -80.20% |
| 2024-12-31 | -59.64% |
| 2024-09-30 | -51.24% |
| 2024-06-30 | -46.06% |
| 2024-03-31 | -38.81% |
| 2023-12-31 | -54.96% |
| 2023-09-30 | -45.09% |
| 2023-06-30 | -38.11% |
| 2023-03-31 | -33.41% |
| 2022-12-31 | -31.78% |
| 2022-09-30 | -29.41% |
| 2022-06-30 | -22.02% |
| 2022-03-31 | -29.49% |
| 2021-12-31 | -18.99% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -51.55% |
| 2024-12-31 | -59.64% |
| 2023-12-31 | -54.96% |
| 2022-12-31 | -31.78% |
| 2021-12-31 | -18.99% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |